Valproic Acid, a Histone Deacetylase Inhibitor, in Combination with Paclitaxel for Anaplastic Thyroid Cancer: Results of a Multicenter Randomized Controlled Phase II/III Trial.
about
Valproic Acid Induces Endocytosis-Mediated Doxorubicin Internalization and Shows Synergistic Cytotoxic Effects in Hepatocellular Carcinoma CellsTargeting hypoxic cancer stem cells (CSCs) with Doxycycline: Implications for optimizing anti-angiogenic therapy.Targeted Therapy for Medullary Thyroid Cancer: A Review.Novel targeted therapies and immunotherapy for advanced thyroid cancers.Inhibition of HDAC3 prevents diabetic cardiomyopathy in OVE26 mice via epigenetic regulation of DUSP5-ERK1/2 pathway.
P2860
Valproic Acid, a Histone Deacetylase Inhibitor, in Combination with Paclitaxel for Anaplastic Thyroid Cancer: Results of a Multicenter Randomized Controlled Phase II/III Trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Valproic Acid, a Histone Deace ...... Controlled Phase II/III Trial.
@en
Valproic Acid, a Histone Deace ...... Controlled Phase II/III Trial.
@nl
type
label
Valproic Acid, a Histone Deace ...... Controlled Phase II/III Trial.
@en
Valproic Acid, a Histone Deace ...... Controlled Phase II/III Trial.
@nl
prefLabel
Valproic Acid, a Histone Deace ...... Controlled Phase II/III Trial.
@en
Valproic Acid, a Histone Deace ...... Controlled Phase II/III Trial.
@nl
P2093
P2860
P921
P356
P1476
Valproic Acid, a Histone Deace ...... Controlled Phase II/III Trial
@en
P2093
Alessandro Piovesan
Emanuela Arvat
Enrico Brignardello
Fabio Orlandi
Giuseppe Boccuzzi
Marco Gallo
Mariateresa Pugliese
Paola Milla
Paolo Piero Limone
P2860
P304
P356
10.1155/2016/2930414
P577
2016-09-27T00:00:00Z